Pharmacor Production receives a 500 million ruble loan

| By | Drug Manufacturing, Investments, Pharmacor

Bank “Aleksandrovsky” provided three credit lines to Pharmacor Production for a total amount of 500 million rubles. The funds borrowed for a period of 3 years were directed to finance the current activities of the company to manufacture medicinal products and biologically active additives.

Dmitry D. Istyufeev, the Deputy Chairman of the Board at the Bank “Aleksandrovsky,” said, “Bank “Aleksandrovsky” established focus groups of experts with in-depth knowledge of industry-specific business areas, including the pharmaceutical market. This enables us to accurately analyze the business prospects of borrowers and get good insights into the needs of clients. We highly appreciate the potential of pharmaceutical industry and Pharmacor Production, which is one of the important players in the regional market. This is why we are ready for a long-term collaboration with the company.”

Elena V. Novikova, the Commercial Director of Pharmacor Production, said, “The strategic plans for the development of Pharmacor Production include growth of production volumes and the increase in the range of products. With the financing received from the Bank “Aleksandrovsky,” we expect to successfully implement our plans.”

PHARMACOR PRODUCTION LLC is a Russian pharmaceutical company founded in 1998. The company has its own production facilities for manufacturing high-quality medicinal products and biologically active additives, as well as a packaging facility for leading European companies. In St. Petersburg, the company has two production sites for manufacturing medicinal products and biologically active additives.